Key result
Diabetes mellitus was not associated with increased 1-year mortality compared to non-diabetic patients following transcatheter aortic valve replacement (22.4% vs. 25.7%; p=0.48).
Why the study?
Does diabetes mellitus worsen mortality and reverse remodeling outcomes in patients undergoing transcatheter aortic valve replacement?
Population
499 consecutive patients who underwent transcatheter aortic valve replacement between 2007 and 2012…
Comparison
Transcatheter aortic valve replacement in… vs Transcatheter aortic valve replacement in…
Design
Cohort
Follow-up
1 year
Authors
Loading...
DM should not yet alter TAVR risk stratification; leaves open effects on reverse remodeling and longer-term outcomes.
Cohort (n=499)
Does diabetes mellitus worsen mortality and reverse remodeling outcomes in patients undergoing transcatheter aortic valve replacement?
Absolute Event Rate: 22.4% vs 25.7%
p-value: p=0.48
Unlike surgical aortic valve replacement, diabetes mellitus does not appear to be associated with poorer mortality outcomes or different reverse remodeling patterns after TAVR.
Minha et al. (2015) conducted a cohort in Aortic stenosis undergoing TAVR (n=499). Diabetes mellitus vs. Non-diabetic was evaluated on Mortality at 1 year (p=0.48). Diabetes mellitus was not associated with increased 1-year mortality compared to non-diabetic patients following transcatheter aortic valve replacement (22.4% vs. 25.7%; p=0.48).
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: